跳至主要内容
13 个市场证据对比

在各市场之间对比单一化妆品物质

输入一个 INCI 名称、化学名称、CAS 或 EC 编号。该工具将欧盟附件证据、关联的成分身份和独立的官方国家记录合并为一份对比。

缺少本地记录会显示为证据缺口,绝不视为准许或安全性结论。

搜索确切身份

为获得最强的身份匹配,当官方来源提供 CAS 或 EC 时,请优先使用它们。
对比查询

206-059-0

在 13 个市场数据集中的 0 个找到了匹配的监管证据。

有证据的市场
0
证据缺口
13
国家记录
0
欧盟附件记录
0
未解析出匹配的监管记录。 请尝试使用确切的 CAS、EC 或官方 INCI 名称。此结果是已索引数据集中的证据缺口,并不证明该物质获准使用或安全。

已解析的身份证据

CAS:298-14-6
EC:206-059-0
3 个匹配或报告的名称
POTASSIUM BICARBONATEpotassium bicarbonatekalii hydrogenocarbonas

按市场划分的监管证据

状态为我们数据集中最强的匹配记录。请打开记录查看确切条件和法律范围。

市场结果记录数据集覆盖范围后续操作
European Union
EU
未找到匹配项0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
未找到匹配项0
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.
Canada
CA
未找到匹配项0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
未找到匹配项0
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative.
ASEAN
ASEAN
未找到匹配项0
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.
China
CN
未找到匹配项0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
未找到匹配项0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
未找到匹配项0
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
United States
US
未找到匹配项0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
未找到匹配项0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
未找到匹配项0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
未找到匹配项0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
未找到匹配项0
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
没有与此筛选条件匹配的市场行。

完成官方核实工作流程

成分证据只是其中一层。这些针对特定市场的步骤列出了作出合规决定之前仍需完成的核查。

European Union · Complete annex dataset
  1. Confirm the exact INCI/CAS/EC identity.
  2. Review every matching Annex II–VI row and its conditions.
  3. Check SCCS opinions, CMR/nanomaterial rules and later amendments.
  4. Verify product classification, claims, labelling and responsible-person duties.
打开市场覆盖范围
Great Britain · Complete consolidated annex dataset
  1. Confirm INCI/CAS/EC identity.
  2. Review every current GB Annex II–VI match.
  3. Check commencement dates and later statutory instruments.
  4. Verify SCPN, responsible-person, safety-report and labelling duties.
打开市场覆盖范围
Canada · Complete Hotlist snapshot
  1. Search English/French names and CAS identifiers.
  2. Apply every restriction, concentration and label warning.
  3. Check Food and Drugs Act/Cosmetic Regulations requirements.
  4. Recheck the current Hotlist before notification or sale.
打开市场覆盖范围
New Zealand · Complete schedules dataset
  1. Search exact identity across Schedules 4–8.
  2. Apply use, concentration and warning conditions.
  3. Check hazardous-substance classification and Group Standard scope.
  4. Confirm the latest legal instrument, not only the spreadsheet.
打开市场覆盖范围
ASEAN · Complete regional annex dataset
  1. Search all ACD annexes by name and identifiers.
  2. Apply product type, maximum level and warning conditions.
  3. Confirm the target member state's adoption and transition date.
  4. Complete the local notification and responsible-company requirements.
打开市场覆盖范围
China · Complete prohibited catalogues plus official-source workflow
  1. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  2. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  3. Review technical purpose, use history and any monitoring period.
  4. Confirm Chinese labelling, safety assessment and filing/registration duties.
打开市场覆盖范围
Japan · Complete Standards appendices dataset
  1. Search Japanese/English identity and CAS where present.
  2. Apply category and maximum-amount conditions.
  3. Check later MHLW notices against the Japanese source.
  4. Verify marketing licence, notification, labelling and quasi-drug classification.
打开市场覆盖范围
South Korea · Complete current appendix dataset
  1. Match the Korean canonical substance name and identifiers.
  2. Review all Appendix 1 and 2 matches and conditions.
  3. Check functional-cosmetic and positive-list requirements where applicable.
  4. Confirm current MFDS notice, responsible seller and label obligations.
打开市场覆盖范围
United States · Complete enumerated federal ingredient rules
  1. Search Part 700 and all relevant colour-additive parts.
  2. Confirm colour additive identity, permitted uses, limits and certification status.
  3. Assess safety and adulteration under the FD&C Act.
  4. Complete MoCRA facility/product, adverse-event and label obligations where applicable.
打开市场覆盖范围
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
  1. Decide whether the product is a cosmetic or therapeutic good.
  2. Check the current Poisons Standard for every ingredient.
  3. Search AICIS Inventory terms and assessment certificates by exact identity.
  4. Determine introduction category, registration, reporting, records and labelling duties.
打开市场覆盖范围
Brazil · Complete prohibited dataset plus current restricted-list workflow
  1. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  2. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  3. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  4. Verify Mercosur incorporation, regularisation, labelling and transition periods.
打开市场覆盖范围
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
  1. Confirm product class and current Cosmetics Rules/gazette amendments.
  2. Check all applicable parts of IS 4707 by exact identity.
  3. Apply Schedule S/other finished-product standards where relevant.
  4. Verify licence/import registration, labelling and testing requirements.
打开市场覆盖范围
Saudi Arabia · Complete official list index
  1. Search names and CAS across both SFDA lists.
  2. Open the cited restricted-entry detail and apply every condition.
  3. Check current SFDA/GSO technical regulations and updates.
  4. Complete eCosma notification, label and responsible-party requirements.
打开市场覆盖范围

本对比能够和不能决定什么

1. 解析身份

CAS 和 EC 标记会被精确提取。名称搜索使用规范化的官方名称和关联的身份。

2. 对比证据

针对每个受支持的市场,分别显示最强的匹配状态和直接记录。

3. 完成核实

产品类型、浓度、纯度、警示语、宣称、分类及后续修订仍需官方审核。